| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.26 | 6e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-06 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |